Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
作者信息
Raj Ashok, Cheerva Alexandra C, Bertolone Salvatore J
出版信息
Int Braz J Urol. 2007 Nov-Dec;33(6):852-3. doi: 10.1590/s1677-55382007000600022.
Abstract
摘要
相似文献
1
Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
Int Braz J Urol. 2007 Nov-Dec;33(6):852-3. doi: 10.1590/s1677-55382007000600022.
2
Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
Int Braz J Urol. 2007 Nov-Dec;33(6):850-1. doi: 10.1590/s1677-55382007000600021.
3
Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
Int Braz J Urol. 2007 Sep-Oct;33(5):704-10. doi: 10.1590/s1677-55382007000500013.
4
Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
Semin Oncol. 1996 Jun;23(3 Suppl 6):97-8.
5
Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention .
Postepy Hig Med Dosw (Online). 2012 Sep 10;66:592-602. doi: 10.5604/17322693.1009703.
6
Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
Indian J Pharmacol. 2014 Jan-Feb;46(1):105-8. doi: 10.4103/0253-7613.125188.
7
Oral administration of mesna with ifosfamide.
Semin Oncol. 1996 Jun;23(3 Suppl 6):91-6.
8
Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
Int Immunopharmacol. 2018 Sep;62:96-108. doi: 10.1016/j.intimp.2018.06.031. Epub 2018 Jul 6.
9
Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.
Urology. 2017 Feb;100:16-19. doi: 10.1016/j.urology.2016.07.030. Epub 2016 Aug 24.
10
[Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
Gan To Kagaku Ryoho. 1995 Jun;22(7):965-8.
Zotero 插件